✦ LIBER ✦

P079 BENEFITS OF DOSAGE ADJUSTMENT WITH ADALIMUMAB IN CROHN'S DISEASE: AN ANALYSIS OF THE CHARM TRIAL

✍ Scribed by W.J. Sandborn; J.F. Colombel; P. Rutgeerts; P.F. Pollack; J. Chao; P. Mulani

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

M1143 Benefits of Dosage Adjustment with

✍ Sandborn, William J.; Colombel, Jean-Frédéric; Rutgeerts, Paul; Pollack, Paul F. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 140 KB

P114 ADALIMUMAB SAFETY IN CROHN'S DISEAS

✍ J.F. Colombel; W.J. Sandborn; W. Reinisch; S.B. Hanauer; P. Rutgeerts; J. Li; P. 📂 Article 📅 2007 🏛 Oxford University Press ⚖ 60 KB

Adalimumab for Maintenance of Clinical R

✍ Jean–Frédéric Colombel; William J. Sandborn; Paul Rutgeerts; Robert Enns; Stephe 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 712 KB

P243 Subgroup analysis of the placebo-co

✍ S. Schreiber; W. Reinisch; J.-F. Colombel; W. Sandborn; A. Robinson; B. Huang; K 📂 Article 📅 2012 🏛 Oxford University Press 🌐 English ⚖ 49 KB

Effect of adalimumab on clinical laborat

✍ David T. Rubin; Parvez Mulani; Jingdong Chao; Paul F. Pollack; Arielle G. Bensim 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 788 KB

P117 - Global safety of adalimumab in tr

✍ J.F. Colombel; R. Panaccione; W.J. Sandborn; P. Rutgeerts; S.B. Hanauer; W. Rein 📂 Article 📅 2009 🏛 Oxford University Press 🌐 English ⚖ 51 KB